Annexin-A1 (ANXA1) could be one of these targets as ANXA1-containing EVs are found to be elevated in the serum of various cancer patients, and ANXA1 was heavily reported to be involved in PC invasion and metastases processes. This evidence concerns the gene ANXA1 and pachyonychia congenita.